Skip to content

Free cash flow at other companies

Merck & Co. logo
Merck & Co.MRK
$2.93B+150%
Zoetis logo
ZoetisZTS
$291M-13.6%
Neogen logo
NeogenNEOG
$11.07M+182%
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
-$229.43M-11,360%
Cardinal Health logo
Cardinal HealthCAH
$1.68B-40.0%
Elanco Animal Health Inc. logo
Elanco Animal Health Inc.ELAN

Other financials

Income statement

See full
Revenue$383.5M+10.3%
Gross profit$125.7M+20.2%
Operating income$44.7M+33.2%
Net income$24.0M+15.1%
EPS (diluted)$0.59+15.7%

Balance sheet

See full
Cash & equivalents$54.9M-9.0%
Total debt$32.3M+27.8%
Total equity$361.8M+36.0%
Total assets$1.4B+9.7%

Cash flow

See full
Operating cash flow$16.2M-62.4%
CapEx$15.3M+97.7%

Valuation

See full
Market cap$1.27B+159%
Enterprise value$1.25B+167%
P/E13.4×-2.1×
P/S0.9×+0.4×

Profitability

See full
Gross margin32.5%+0.9pp
Operating margin12%+4.0pp
Net margin6.3%+3.7pp
FCF margin0.9%-3.3pp

Returns & leverage

See full
Return on equity30.3%+18.5pp
Debt / equity0.1×0.0×
Current ratio3.2×+0.3×

Where this comes from

Calculated from Phibro Animal Health’s reported figures.

The official record: Phibro Animal Health’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Phibro Animal Health's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Phibro Animal Health's free cash flow?
Phibro Animal Health (PAHC) reported free cash flow of $890K in Q1 2026.
How has Phibro Animal Health's free cash flow changed year-over-year?
Phibro Animal Health's free cash flow decreased by 97.5% year-over-year, from $35.41M to $890K.
What is the long-term trend for Phibro Animal Health's free cash flow?
Over 2 years (2022 to 2025), Phibro Animal Health's free cash flow has grown at a 178.5% compound annual growth rate (CAGR), from -$5.4M to $41.83M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.